发明名称 AROMATIC SULFONES AND THEIR MEDICAL USE
摘要 <p>The invention provides compounds of formula (I): wherein A and B represent the groups -(CH<SUB>2</SUB>)<SUB>m</SUB>- and -(CH<SUB>2</SUB>)<SUB>n</SUB>- respectively; R<SUP>1 </SUP>represents hydrogen or C<SUB>1-6</SUB>alkyl; R<SUP>2 </SUP>represents hydrogen, halogen, hydroxy, cyano, nitro, hydroxy C<SUB>1-6</SUB>alkyl, trifluoromethyl, trifluoromethoxy, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy, C<SUB>1-6</SUB>fluoroalkoxy, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyl, -(CH<SUB>2</SUB>)<SUB>p</SUB>OC<SUB>3-6</SUB>cycloalkyl, -COC<SUB>1-6</SUB>alkyl, -SO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -SOC<SUB>1-6</SUB>alkyl, -S-C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>C<SUB>1-6</SUB>alkyl, -CO<SUB>2</SUB>NR<SUP>5</SUP>R<SUP>6</SUP>, -SO<SUB>2</SUB>NR<SUP>5</SUP>R<SUP>6</SUP>, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>5</SUP>R<SUP>6</SUP>, -(CH<SUB>2</SUB>)<SUB>p</SUB>NR<SUP>5</SUP>COR<SUP>6</SUP>, optionally substituted aryl ring, optionally substituted heteroaryl ring or optionally substituted heterocyclyl ring; R<SUP>3 </SUP>represents optionally substituted aryl ring or optionally substituted heteroaryl ring; R<SUP>4 </SUP>represents hydrogen, hydroxy, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkoxy, trifluoromethyl, trifluoromethoxy, halogen, -OSO<SUB>2</SUB>CF<SUB>3</SUB>, -(CH<SUB>2</SUB>)<SUB>p</SUB>C<SUB>3-6</SUB>cycloalkyl, -(CH<SUB>2</SUB>)<SUB>q</SUB>OC<SUB>1-6</SUB>alkyl or -(CH<SUB>2</SUB>)<SUB>p</SUB>OC<SUB>3-6</SUB>cycloalkyl; R<SUP>5 </SUP>and R<SUP>6 </SUP>each independently represent hydrogen, C<SUB>1-6</SUB>alkyl or, together with the nitrogen or other atoms to which they are attached, form an azacycloalkyl ring or an oxo-substituted azacycloalkyl ring; Z represents -(CH<SUB>2</SUB>)<SUB>r</SUB>X- wherein the -(CH<SUB>2</SUB>)<SUB>r</SUB>- group is attached to R<SUP>3</SUP>, or -X(CH<SUB>2</SUB>)<SUB>r</SUB>- wherein X is attached to R<SUP>3</SUP>, and wherein any of the -CH<SUB>2</SUB>- groups may be optionally substituted by one or more C<SUB>1-6</SUB>alkyl groups; X represents oxygen, -NR<SUP>7 </SUP>or -CH<SUB>2</SUB>- wherein the -CH<SUB>2</SUB>- group may be optionally substituted by one or more C<SUB>1-6</SUB>alkyl groups; R<SUP>7 </SUP>represents hydrogen or C<SUB>1-6</SUB>alkyl; m and n independently represent an integer selected from 1 and 2; p independently represents an integer selected from 0, 1, 2 and 3; q independently represents an integer selected from 1, 2 and 3; r independently represents an integer selected from 0, 1, and 2; or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful in therapy, in particular as antipsychotic agents.</p>
申请公布号 SI1511727(T1) 申请公布日期 2007.06.30
申请号 SI20030030757T 申请日期 2003.05.28
申请人 GLAXO GROUP LIMITED 发明人 GRIBBLE ANDREW DERRICK;FORBES IAN THOMSON;LIGHTFOOT ANDREW;PAYNE ANDREW H;WALKER GRAHAM;GARZYA VINCENZO
分类号 C07D217/22;A61K;A61K31/4035;A61K31/47;A61K31/4704;A61K31/472;A61K31/55;A61P;A61P1/00;A61P1/08;A61P3/04;A61P15/00;A61P25/00;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/36;A61P43/00;C07D;C07D209/44;C07D217/02;C07D223/16;C07D401/12;C07D405/12;C07D409/12;C07D413/12;C07D417/12 主分类号 C07D217/22
代理机构 代理人
主权项
地址